We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
-18.54%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$1.68B
AUM Growth
-$820M
(-33%)
Cap. Flow
-$224M
Cap. Flow
% of AUM
-13.29%
Top 10 Holdings %
Top 10 Hldgs %
80.09%
Holding
61
New
4
Increased
11
Reduced
4
Closed
15
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
+$55M |
| 2 |
Zymeworks
ZYME
|
+$30.4M |
| 3 |
AKRO
Akero Therapeutics
AKRO
|
+$18.7M |
| 4 |
Beam Therapeutics
BEAM
|
+$13.8M |
| 5 |
uniQure
QURE
|
+$8.26M |
Top Sells
| 1 |
Arvinas
ARVN
|
+$129M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$56.4M |
| 3 |
THRD
Third Harmonic Bio
THRD
|
+$32.7M |
| 4 |
Neumora Therapeutics
NMRA
|
+$22M |
| 5 |
CRGX
CARGO Therapeutics
CRGX
|
+$21.2M |
Sector Composition
| 1 | Healthcare | 99.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1
DELISTED
Apellis Pharmaceuticals
APLS
| $260M | 15.45% |
11,895,808
+4,965
| +0% | +$137K |
|
2
Jazz Pharmaceuticals
JAZZ
$15.1B
| $212M | 12.58% |
1,706,469
| – | – |
|
|
3
Zymeworks
ZYME
$1.81B
| $206M | 12.21% |
17,259,548
+2,231,469
| +15% | +$30.4M |
|
4
AnaptysBio
ANAB
$1.67B
| $146M | 8.7% |
7,880,094
+6,646
| +0.1% | +$111K |
|
5
Crinetics Pharmaceuticals
CRNX
$8.88B
| $144M | 8.54% |
4,288,120
| – | – |
|
6
Prothena Corp
PRTA
$450M
| $143M | 8.51% |
11,584,280
| – | – |
|
|
7
Sarepta Therapeutics
SRPT
$1.83B
| $82.5M | 4.9% |
1,292,386
+522,386
| +68% | +$55M |
|
8
Xencor
XNCR
$1.1B
| $65.4M | 3.88% |
6,144,767
| – | – |
|
9
CRISPR Therapeutics
CRSP
$4.99B
| $47.3M | 2.81% |
1,389,276
| – | – |
|
|
10
uniQure
QURE
$2.8B
| $42.3M | 2.51% |
3,988,971
+588,971
| +17% | +$8.26M |
|
11
Janux Therapeutics
JANX
$972M
| $39.7M | 2.36% |
1,469,818
| – | – |
|
12
Immunome
IMNM
$2.57B
| $27.5M | 1.63% |
4,079,415
+200,000
| +5% | +$1.92M |
|
13
Eton Pharmaceutcials
ETON
$1.05B
| $25.2M | 1.49% |
1,939,288
+109,685
| +6% | +$1.66M |
|
14
Madrigal Pharmaceuticals
MDGL
$12.6B
| $24.8M | 1.48% |
75,000
| – | – |
|
15
Oric Pharmaceuticals
ORIC
$1.15B
| $19.1M | 1.13% |
3,418,068
| – | – |
|
|
AKRO
16
DELISTED
Akero Therapeutics
AKRO
| $17.8M | 1.06% |
+440,000
| New | +$18.7M |
|
17
Kura Oncology
KURA
$1B
| $17.4M | 1.03% |
2,640,298
-916,971
| -26% | -$7.15M |
|
|
TECX
18
Tectonic Therapeutic
TECX
$613M
| $16.6M | 0.98% |
935,121
+85,978
| +10% | +$2.8M |
|
|
RNAM
19
DELISTED
Avidity Biosciences
RNAM
| $16.5M | 0.98% |
557,576
| – | – |
|
20
Neurogene
NGNE
$787M
| $14.9M | 0.88% |
1,271,342
| – | – |
|
21
Tango Therapeutics
TNGX
$4.92B
| $14.6M | 0.86% |
10,630,736
| – | – |
|
22
Voyager Therapeutics
VYGR
$192M
| $13.2M | 0.79% |
3,917,546
| – | – |
|
|
23
Beam Therapeutics
BEAM
$3.19B
| $10.3M | 0.61% |
+526,685
| New | +$13.8M |
|
|
MBX
24
MBX Biosciences
MBX
$2.83B
| $9.29M | 0.55% |
1,259,273
| – | – |
|
25
Ginkgo Bioworks
DNA
$587M
| $8.34M | 0.5% |
1,462,328
-281,016
| -16% | -$2.86M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM